120 related articles for article (PubMed ID: 22729890)
1. A 24-color metaphase-based radiation assay discriminates heterozygous BRCA2 mutation carriers from controls by chromosomal radiosensitivity.
Becker AA; Graeser MK; Landwehr C; Hilger T; Baus W; Wappenschmidt B; Meindl A; Weber RG; Schmutzler RK
Breast Cancer Res Treat; 2012 Aug; 135(1):167-75. PubMed ID: 22729890
[TBL] [Abstract][Full Text] [Related]
2. Increased chromosomal radiosensitivity in women carrying BRCA1/BRCA2 mutations assessed with the G2 assay.
Ernestos B; Nikolaos P; Koulis G; Eleni R; Konstantinos B; Alexandra G; Michael K
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1199-205. PubMed ID: 20206018
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal mutagen sensitivity associated with mutations in BRCA genes.
Speit G; Trenz K
Cytogenet Genome Res; 2004; 104(1-4):325-32. PubMed ID: 15162060
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage.
Nieuwenhuis B; Van Assen-Bolt AJ; Van Waarde-Verhagen MA; Sijmons RH; Van der Hout AH; Bauch T; Streffer C; Kampinga HH
Int J Radiat Biol; 2002 Apr; 78(4):285-95. PubMed ID: 12020440
[TBL] [Abstract][Full Text] [Related]
5. Lower level of BRCA2 protein in heterozygous mutation carriers is correlated with an increase in DNA double strand breaks and an impaired DSB repair.
Arnold K; Kim MK; Frerk K; Edler L; Savelyeva L; Schmezer P; Wiedemeyer R
Cancer Lett; 2006 Nov; 243(1):90-100. PubMed ID: 16448746
[TBL] [Abstract][Full Text] [Related]
6. Ionizing radiation or mitomycin-induced micronuclei in lymphocytes of BRCA1 or BRCA2 mutation carriers.
Gutiérrez-Enríquez S; Ramón Y Cajal T; Alonso C; Corral A; Carrasco P; Cornet M; Sanz J; Ribas M; Baiget M; Diez O
Breast Cancer Res Treat; 2011 Jun; 127(3):611-22. PubMed ID: 20625817
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility.
Barwell J; Pangon L; Georgiou A; Kesterton I; Langman C; Arden-Jones A; Bancroft E; Salmon A; Locke I; Kote-Jarai Z; Morris JR; Solomon E; Berg J; Docherty Z; Camplejohn R; Eeles R; Hodgson SV
Int J Cancer; 2007 Oct; 121(7):1631-6. PubMed ID: 17582599
[TBL] [Abstract][Full Text] [Related]
8. Increased rates of spontaneous sister chromatid exchange in lymphocytes of BRCA2+/- carriers of familial breast cancer clusters.
Kim MK; Zitzmann S; Westermann F; Arnold K; Brouwers S; Schwab M; Savelyeva L
Cancer Lett; 2004 Jul; 210(1):85-94. PubMed ID: 15172125
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal instability induced by mammography X-rays in primary human fibroblasts from BRCA1 and BRCA2 mutation carriers.
Frankenberg-Schwager M; Gregus A
Int J Radiat Biol; 2012 Nov; 88(11):846-57. PubMed ID: 22788243
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers.
Baeyens A; Thierens H; Claes K; Poppe B; de Ridder L; Vral A
Int J Radiat Biol; 2004 Oct; 80(10):745-56. PubMed ID: 15799620
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.
Beetstra S; Salisbury C; Turner J; Altree M; McKinnon R; Suthers G; Fenech M
Carcinogenesis; 2006 Mar; 27(3):517-24. PubMed ID: 16162645
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity of lymphoblastoid cell lines with a heterozygous BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis.
Trenz K; Schütz P; Speit G
Mutagenesis; 2005 Mar; 20(2):131-7. PubMed ID: 15784691
[TBL] [Abstract][Full Text] [Related]
13. Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay.
Baert A; Depuydt J; Van Maerken T; Poppe B; Malfait F; Van Damme T; De Nobele S; Perletti G; De Leeneer K; Claes KB; Vral A
Oncol Rep; 2017 Mar; 37(3):1379-1386. PubMed ID: 28184943
[TBL] [Abstract][Full Text] [Related]
14. Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2.
Buchholz TA; Wu X; Hussain A; Tucker SL; Mills GB; Haffty B; Bergh S; Story M; Geara FB; Brock WA
Int J Cancer; 2002 Feb; 97(5):557-61. PubMed ID: 11807777
[TBL] [Abstract][Full Text] [Related]
15. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM
Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180
[TBL] [Abstract][Full Text] [Related]
16. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients.
Chistiakov DA; Voronova NV; Chistiakov PA
Acta Oncol; 2008; 47(5):809-24. PubMed ID: 18568480
[TBL] [Abstract][Full Text] [Related]
17. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families.
Rothfuss A; Schütz P; Bochum S; Volm T; Eberhardt E; Kreienberg R; Vogel W; Speit G
Cancer Res; 2000 Jan; 60(2):390-4. PubMed ID: 10667592
[TBL] [Abstract][Full Text] [Related]
18. Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2.
Foray N; Randrianarison V; Marot D; Perricaudet M; Lenoir G; Feunteun J
Oncogene; 1999 Dec; 18(51):7334-42. PubMed ID: 10602489
[TBL] [Abstract][Full Text] [Related]
19. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
20. ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers.
Adem C; Soderberg CL; Hafner K; Reynolds C; Slezak JM; Sinclair CS; Sellers TA; Schaid DJ; Couch F; Hartmann LC; Jenkins RB
Genes Chromosomes Cancer; 2004 Sep; 41(1):1-11. PubMed ID: 15236312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
